|Bid||24.54 x 800|
|Ask||24.44 x 1100|
|Day's range||24.35 - 25.54|
|52-week range||17.90 - 34.19|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||34.53|
|Earnings date||17 Nov 2021 - 22 Nov 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||34.79|
Investors are optimistic about Quest Diagnostics (DGX) backed by its strong second-quarter performance and recovery in the base testing business.
BRBR, CNHI, DLA, FNF, and RM have been added to the Zacks Rank #1 (Strong Buy) List on September 29, 2021.
Medtronic's (MDT) Hugo RAS system is a modular, multi-quadrant platform intended for a broad range of soft-tissue procedures.